$21.87 0.07 (+0.32%)
2/9/2010 4:03 PM

IMS Health, Inc. (RX)

CAPS Rating: 3 out of 5

The Company provides critical business intelligence, including information, analytics and consulting services to the pharmaceutical and healthcare industries worldwide.

Recs

0
Member Avatar KempInTheWoods (69.89) Submitted: 9/14/2009 10:50:03 AM : Outperform Start Price: $14.69 RX Score: +45.95

Currently undervalued. Wide moat: information on drug sales from wide variety of sources. Pharma companies have temporarily cut back on IMS's services, but longer term will have to come back to them.

Report this Post 0 Comments

Featured Broker Partners